Perspective Therapeutics (CATX) Earnings Date & Reports

Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering variousÂ treatment applications for cancers throughout the body... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CATX is expected to report earnings to rise 26.67% to -26 cents per share on March 26

Perspective Therapeutics CATX Stock Earnings Reports

Q4'24

Est.

$-0.27

Q3'24

Est.

$-0.21

Q2'24

Missed

by $0.16

Q1'24

Est.

$-0.02

Q4'23

Missed

by $0.03

The last earnings report on November 12 showed earnings per share of -20 cents, meeting the estimate of -20 cents. With 82.23K shares outstanding, the current market capitalization sits at 751.25M.

View a ticker or compare two or three

Compare

CATX